Login

GW PHARMACEUTICALS PLC 3 SEC Filings

Filed On Filing
16 Sep 2020 Form 3: Gryska David W, Director

Holds 0 shares of No securities are beneficially owned

01 May 2019 Form 3: Cline Darren S, U.S. Chief Commercial Officer

No securities owned

01 Oct 2018 Form 3: Knappertz Volker, Chief Medical Officer

Holds 8,172 shares of Ordinary Shares

01 Oct 2018 Form 3: Guy Geoffrey W Dr, Director

Holds 9,041,521 shares of Ordinary Shares

01 Oct 2018 Form 3: Waldegrave William A., Director
01 Oct 2018 Form 3: Tovey Christopher J., Chief Operating Officer

Holds 2,503 shares of Ordinary Shares

01 Oct 2018 Form 3: Noble James, Director

Holds 27,500 shares of Ordinary Shares

01 Oct 2018 Form 3: Snyder Douglas B., Chief Legal Officer
01 Oct 2018 Form 3: Secor Alicia, Director
01 Oct 2018 Form 3: Mackey Catherine J, Director
01 Oct 2018 Form 3: Lynch Thomas G, Director
01 Oct 2018 Form 3: Gover Justin D., Director

Holds 370,445 shares of Ordinary Shares

01 Oct 2018 Form 3: Giacobello Scott M., Chief Financial Officer

Holds 5,364 shares of Ordinary Shares

01 Oct 2018 Form 3: George Adam D., Secretary

Holds 5,921 shares of Ordinary Shares

01 Oct 2018 Form 3: Gangolli Julian S, President, North America

Holds 101,292 shares of Ordinary Shares

01 Oct 2018 Form 3: Brown Cabot, Director

Holds 7,200 shares of Ordinary Shares

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support